Ensign Peak Advisors’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $566K | Hold |
|
|||||
|
2025
Q1 | $806K | Hold |
|
|||||
|
2024
Q4 | $931K | Hold |
|
|||||
|
2024
Q3 | $1.06M | Hold |
|
|||||
|
2024
Q2 | $980K | Hold |
|
|||||
|
2024
Q1 | $1.16M | Sell |
|
|||||
|
2023
Q4 | $1.47M | Hold |
|
|||||
|
2023
Q3 | $1.26M | Hold |
|
|||||
|
2023
Q2 | $1.3M | Buy |
|
|||||
|
2023
Q1 | $1.1M | Hold |
|
|||||
|
2022
Q4 | $1.21M | Buy |
|
|||||
|
2022
Q3 | $588K | Sell |
|
|||||
|
2022
Q2 | $2.51M | Buy |
|
|||||
|
2022
Q1 | $532K | Buy |
|
|||||
|
2021
Q4 | $531K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $2.71M | Sell |
|
|||||
|
2020
Q3 | $1.84M | Buy |
|
|||||
|
2020
Q2 | $92K | Hold |
|
|||||
|
2020
Q1 | $56K | Sell |
|
|||||
|
2019
Q4 | $129K | Buy |
|